Brighter receives final approvals for pilot research with insulin-treated diabetes patients in the UAE
Brighter AB (Publ) (“Brighter” or “The Company”) today announces that it has received ethical approval for the research pilot in the United Arab Emirates. The approval is granted by the country's Ministry of Health and Prevention’s (MoHAP) research ethics committee. The approval marks the last local requirement that was needed to start the pilot. What remains now is to finalize the training of the healthcare providers, and then start onboarding patients. In addition to the ethical approval, the UAE Ministry of Health has also granted Brighter import-clearance approval. Pilot